VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Pelthos Therapeutics Inc. (PTHS) Total Return Calculator with Dividends Reinvested

Pelthos Therapeutics Inc.

Popular:

The total return for Pelthos Therapeutics Inc. (PTHS) stock is +111.86% over the past 12 months. So far it's down 15.11% this year. The 5-year total return is +111.86%, meaning $10,000 invested in PTHS stock 5 years ago would be worth $21,186 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in PTHS 1 year ago, it would be worth $21,186 today — you'd have gained $11,186.

With Dividends Reinvested$21,186+111.86%

Price Only (No DRIP)$21,186+111.86%

Period2025-06-25 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in PTHS

1Y$21,186+$11,186 (+111.9%)111.9% CAGR

3Y$21,186+$11,186 (+111.9%)28.4% CAGR

5Y$21,186+$11,186 (+111.9%)16.2% CAGR

10Y$21,186+$11,186 (+111.9%)7.8% CAGR

15Y$21,187+$11,187 (+111.9%)5.1% CAGR

20Y$21,186+$11,186 (+111.9%)3.8% CAGR

30Y$21,187+$11,187 (+111.9%)2.5% CAGR

Pelthos Therapeutics Inc. did not pay dividends during this period. Total return = price return.

Loading PTHS total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-15.11%	—	-15.11%	—	$8,489
1Y	+111.86%	111.86%	+111.86%	—	$21,186
3Y	+111.86%	28.44%	+111.86%	—	$21,186
5Y	+111.86%	16.20%	+111.86%	—	$21,186
10Y	+111.86%	7.80%	+111.86%	—	$21,186
15Y	+111.87%	5.13%	+111.87%	—	$21,187
20Y	+111.86%	3.83%	+111.86%	—	$21,186
30Y	+111.87%	2.53%	+111.87%	—	$21,187

Risk & Highlights

Best Year+162.71%2025

Max Drawdown-47.62%2025-11-06 → 2026-02-18

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-10.49%	-10.49%	—	+0.41%	-10.9pp
2025	+162.71%	+162.71%	—	+16.64%	+146.1pp

PTHS outperformed the S&P 500 by 80.54pp over the past year (+111.86% vs +31.32%).

Loading summary...

PTHS Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
PTHSPelthos Therapeutics Inc.	$15M	+0.0%	-15.1%	+111.9%	—	+111.9%	+111.9%	+111.9%
COLLCollegium Pharmaceutical, Inc.	$1.2B	+12.0%	-19.8%	+35.1%	—	+55.9%	+66.4%	+141.8%
AVDLAvadel Pharmaceuticals plc	$2.1B	—	+0.6%	+150.5%	—	+45.8%	+174.6%	+99.3%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+1.8%	+4.0%	+58.6%	—	+39.8%	+75.7%	+240.3%
LNTHLantheus Holdings, Inc.	$5.6B	+13.5%	+28.1%	-17.8%	—	-9.1%	+290.0%	+4002.4%
PRAXPraxis Precision Medicines, Inc.	$7.6B	+9.0%	+18.0%	+860.9%	—	+2005.6%	-18.4%	-19.0%
ACADACADIA Pharmaceuticals Inc.	$3.7B	-3.8%	-17.9%	+47.7%	—	-0.3%	+2.5%	-22.3%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%
PCRXPacira BioSciences, Inc.	$932M	+6.4%	-3.1%	-5.8%	—	-43.9%	-62.5%	-50.0%
PRGOPerrigo Company plc	$1.7B	+15.8%	-9.6%	-45.6%	+4.7pp	-56.6%	-58.6%	-76.8%
MCKMcKesson Corporation	$91.1B	-13.2%	-9.6%	+5.0%	+0.4pp	+104.0%	+308.4%	+351.9%

Compare:PTHS vs COLL PTHS vs AVDL PTHS vs SUPN PTHS vs COLL vs AVDL

About PTHS Dividend Returns

Pelthos Therapeutics Inc. (PTHS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of PTHS over the past year?

Pelthos Therapeutics Inc. (PTHS) delivered a return of 111.86% over the past year. Since PTHS does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in PTHS be worth today?

A $10,000 investment in Pelthos Therapeutics Inc. one year ago would be worth $21,186 today, representing a gain of $11,186.

Q3Does PTHS pay dividends?

Pelthos Therapeutics Inc. (PTHS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PTHS, the total return equals the price-only return.

Q4Did PTHS beat the S&P 500?

Yes, Pelthos Therapeutics Inc. (PTHS) outperformed the S&P 500 by 80.54 percentage points over the past year. PTHS delivered a total return of 111.86%, compared to the S&P 500's 31.32%. This 80.54pp alpha means investors in PTHS earned more than a passive S&P 500 index fund.

Q5What is PTHS's worst drawdown?

Pelthos Therapeutics Inc. (PTHS) experienced a maximum drawdown of -47.62% over the past year, declining from its peak on 2025-11-06 to its trough on 2026-02-18. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is PTHS's long-term total return over 10, 20, or 30 years?

Here are Pelthos Therapeutics Inc. (PTHS)'s long-term returns with dividends reinvested. Over 10 years, the total return is 111.9% (7.8% CAGR) — $10,000 would have grown to $21,186. Over 20 years: 111.9% total return (3.8% CAGR) — $10,000 → $21,186. Over 30 years: 111.9% total return (2.5% CAGR) — $10,000 → $21,187. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.